PMC:7212965 / 37500-37891 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T178","span":{"begin":201,"end":209},"obj":"Disease"},{"id":"T179","span":{"begin":355,"end":362},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"mondo_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0005136"}],"text":"ated adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources).\n\nAntimalarial Medications\nAlthough efficacy and subsequent optimal dosing in COVID-19 is still under investigation, both chloroquine and hydroxychloroquine are currently FDA-approved in the United States for other indications (ie, malaria and systemic lupus erythemat"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T61","span":{"begin":245,"end":256},"obj":"Chemical"},{"id":"T62","span":{"begin":261,"end":279},"obj":"Chemical"}],"attributes":[{"id":"A61","pred":"chebi_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"ated adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources).\n\nAntimalarial Medications\nAlthough efficacy and subsequent optimal dosing in COVID-19 is still under investigation, both chloroquine and hydroxychloroquine are currently FDA-approved in the United States for other indications (ie, malaria and systemic lupus erythemat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T234","span":{"begin":125,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ated adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources).\n\nAntimalarial Medications\nAlthough efficacy and subsequent optimal dosing in COVID-19 is still under investigation, both chloroquine and hydroxychloroquine are currently FDA-approved in the United States for other indications (ie, malaria and systemic lupus erythemat"}

{"project":"LitCovid-PubTator","denotations":[{"id":"948","span":{"begin":245,"end":256},"obj":"Chemical"},{"id":"949","span":{"begin":261,"end":279},"obj":"Chemical"},{"id":"950","span":{"begin":201,"end":209},"obj":"Disease"},{"id":"951","span":{"begin":355,"end":362},"obj":"Disease"}],"attributes":[{"id":"A948","pred":"tao:has_database_id","subj":"948","obj":"MESH:D002738"},{"id":"A949","pred":"tao:has_database_id","subj":"949","obj":"MESH:D006886"},{"id":"A950","pred":"tao:has_database_id","subj":"950","obj":"MESH:C000657245"},{"id":"A951","pred":"tao:has_database_id","subj":"951","obj":"MESH:D008288"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ated adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources).\n\nAntimalarial Medications\nAlthough efficacy and subsequent optimal dosing in COVID-19 is still under investigation, both chloroquine and hydroxychloroquine are currently FDA-approved in the United States for other indications (ie, malaria and systemic lupus erythemat"}